FDA Pulls Unauthorized OTC Anti-Microbial Products

Law360, New York (September 9, 2009, 12:49 PM EDT) -- The U.S. Food and Drug Administration has reached a deal with officers of Care-Tech Laboratories Inc. in which the company will stop manufacturing, marketing and distributing more than a dozen unapproved over-the-counter anti-microbial product lines that raised red flags during a recent FDA inspection.

St. Louis-based Care-Tech principal officers John C. and Sherry L. Brereton signed a consent decree with the FDA in which they agreed to pull the plug on 16 Care-Tech brands until the company has corrected good manufacturing practice violations and received agency...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.